Concepedia
Statistics
Publications
7
Citations
506
H-Index
Active since
2015
Affiliations
VA Tennessee Valley Healthcare System(Current)
Vanderbilt University
Vanderbilt University Medical Center
The Ohio State University
Cancer Research And Biostatistics
Christopher Andrew Johnson is an author at VA Tennessee Valley Healthcare System specializing in oncology, medicine, and immunology.
Publications per year
2015–2020
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21
Anna E. Vilgelm, Nabil Saleh, Rebecca L. Shattuck-Brandt et al. · Science Translational Medicine · 2019 · 135 citations · Full text
Medicine, Cancer Biology, Oncology +16
Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity
Jinming Yang, Chi Yan, Anna E. Vilgelm et al. · Cancer Immunology Research · 2020 · 111 citations · Full text
Medicine, Immunology, Oncology +17
Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment
Anna E. Vilgelm, Christopher Andrew Johnson, Nripesh Prasad et al. · JNCI Journal of the National Cancer Institute · 2015 · 94 citations · Full text
Multimodal Multiplexed Immunoimaging with Nanostars to Detect Multiple Immunomarkers and Monitor Response to Immunotherapies
Yu‐Chuan Ou, Xiaona Wen, Christopher Andrew Johnson et al. · ACS Nano · 2019 · 63 citations · Full text
Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition
Rebecca L. Shattuck-Brandt, Sheau‐Chiann Chen, Emily Murray et al. · Clinical Cancer Research · 2020 · 48 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 7